[VIVO] QoQ Quarter Result on 30-Sep-2022 [#Q4]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
22-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q4]
Profit Trend
QoQ- 177.75%
YoY- -14.30%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 56,902 65,675 67,771 111,231 88,341 76,204 63,511 -7.04%
PBT -29,097 4,633 -6,602 36,535 19,751 7,856 15,295 -
Tax 724 -1,072 736 7,783 4,411 1,199 3,626 -65.73%
NP -29,821 5,705 -7,338 28,752 15,340 6,657 11,669 -
Tax Rate - 23.14% - -21.30% -22.33% -15.26% -23.71% -
Total Cost 86,723 59,970 75,109 82,479 73,001 69,547 51,842 40.78%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -52.41 8.69 -10.83 25.85 17.36 8.74 18.37 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.68 0.13 -0.16 0.65 0.35 0.15 0.27 -
EPS Diluted -0.68 0.13 -0.16 0.65 0.35 0.15 0.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.